Dr. dr. Laurentius Aswin Pramono, M.Epid., M.Med.Ed., SpPD-KEMD is an internist and subspecialist in endocrinology, metabolism, and diabetes who practices at JEC Menteng Eye Hospital. In addition to managing preoperative eye surgery preparation and providing general internal medicine care, Dr. Aswin has special expertise and a strong interest in the management of diabetes and its complications, including diabetes-related eye disorders such as retinopathy, cataracts, and glaucoma.

His clinical interests also include thyroid disorders such as hyperthyroidism, hypothyroidism, autoimmune thyroid disease, thyroid nodules, and thyroid cancer, as well as thyroid eye disease (Graves’ ophthalmopathy). He has extensive experience in managing various hormonal disorders, including pituitary, adrenal, and reproductive (sexual) hormone disorders, parathyroid disease and osteoporosis, dyslipidemia (cholesterol disorders), metabolic syndrome, and obesity.

Dr. Aswin has been practicing at JEC Menteng Eye Hospital since completing his internal medicine specialist training in early 2016. With nearly 10 years of clinical experience, he has managed a wide range of internal medicine conditions related to eye health, including endocrine and metabolic diseases, allergic and rheumatic-autoimmune disorders, coagulation abnormalities, tumors (such as pituitary tumors or brain tumors affecting the optic nerve), and infectious diseases (including tuberculosis, HIV, and toxoplasmosis) with systemic involvement.

In his daily practice, he works closely with the ophthalmology team at JEC Menteng to provide comprehensive preoperative and postoperative care and to optimize the recovery of patients with eye disorders from an internal medicine perspective.

Dr. Aswin is also a member of the Thyroid Eye Center team at JEC Menteng Eye Hospital, where he is actively involved in managing patients with thyroid eye disease (Graves’ ophthalmopathy). Established in 2023, the JEC Menteng Thyroid Eye Center has extensive experience in treating a wide range of thyroid eye disease cases, from diagnosis to medical management with steroids, immunosuppressants, and monoclonal antibodies, as well as surgical interventions such as orbital decompression, eyelid surgery, and strabismus surgery, with excellent outcomes.

Currently, JEC Menteng Eye Hospital is recognized as one of the leading referral centers for thyroid eye disease management in Indonesia, offering the most comprehensive services and managing the highest patient volume in this field.

Services

• General internal medicine, endocrinology, metabolism, and diabetes consultations
• Perioperative eye care consultations (preoperative and postoperative management)
• Medical check-up results consultation and interpretation
• Palliative care and end-of-life care consultations
• Emergency care in internal medicine
• Management of diabetes and its complications, including diabetes-related eye disorders
• Management of thyroid disorders and thyroid eye disease (Graves’ ophthalmopathy)
• Management of endocrine disorders, including pituitary, adrenal, osteoporosis, and reproductive disorders
• Management of dyslipidemia, obesity, and metabolic syndrome
• Management of internal medicine conditions (autoimmune, rheumatic, hematologic-oncologic, endocrine-metabolic, and infectious diseases) with ocular manifestations
• Thyroid and neck ultrasonography
• Electrocardiography (ECG) and radiological examinations (chest X-ray)
• Comprehensive laboratory services

• Medical Doctor (MD), Faculty of Medicine, Universitas Indonesia (2003 – 2009)
• Master’s Degree in Clinical Epidemiology, Faculty of Public Health, Universitas Indonesia (2008 – 2010)
• Specialist in Internal Medicine, Faculty of Medicine, Universitas Indonesia (2011 – 2015)
• Consultant in Endocrinology, Metabolism, and Diabetes, Faculty of Medicine, Universitas Indonesia (2020 – 2022)
• Doctoral Degree (PhD) in Clinical Epidemiology, Faculty of Public Health, Universitas Indonesia (2021 – 2024)
• Master’s Degree in Medical Education, Faculty of Medicine, Universitas Indonesia (2023 – 2025)

• European Group on Graves’ Orbitopathy (EuGOGO) Teaching Course, Munich, Germany (2016)
• 7th EMSS–Mayo Course in Advanced Endocrinology and Pre-Course in Radiology in Endocrinology, Endocrine & Metabolic Society of Singapore, Singapore (2018)
• 1st IDF Diabetes Complications Congress, Hyderabad, India (2018)
• 5th International Thyroid Eye Disease Society (ITEDS) Symposium, Singapore (2019)
• World Congress on Thyroid Cancer and Advanced Thyroid Ultrasound Course, Rome, Italy (2019)
• 17th Asia Oceania Congress of Endocrinology – 8th Seoul International Congress of Endocrinology and Metabolism (AOCE–SICEM), Virtual (Seoul, 2020)
• 10th Multidisciplinary Thyroid Cancer Symposium, Virtual (Pittsburgh, USA, 2020)
• 8th EMSS–Mayo Course in Advanced Endocrinology and Pre-Course in Endocrinology and Pregnancy, Endocrine & Metabolic Society of Singapore, Virtual (Singapore, 2020)
• Asian Federation of Osteoporosis Societies (AFOS) Congress and Osteoporosis Essentials Course, Virtual (Singapore, 2022)
• 9th EMSS–Mayo Course in Advanced Endocrinology and Pre-Course in Endocrinology and Pregnancy, Virtual (Singapore, 2022)
• Pituitary Preceptorship 2023, University of Malaya Medical Centre, Virtual (Kuala Lumpur, Malaysia, 2023)
• Intermediate Neck Ultrasound Training, PUSKI and WFUMB, Jakarta, Indonesia (2023)
• 1st Asia Pacific Orbital Disease and Thyroid Eye Disease Meeting, Singapore (2023)
• World Congress on Thyroid Cancer, London, United Kingdom (2023)
• 10th EMSS–Mayo Course in Advanced Endocrinology, Endocrine & Metabolic Society of Singapore (2024)
• 14th Congress of the Asia Oceania Thyroid Association (AOTA), Bali, Indonesia (2024)
• Asia Pacific Consortium on Osteoporosis and Singapore Osteoporosis and Other Metabolic Bone Disorders Summit (APCO–SOOMBODS), Singapore (2024)
• EORTC Quality of Life in Cancer Clinical Trials Conference, Barcelona, Spain (2025)
• Palliative Care Training, Dharmais National Cancer Hospital, Jakarta, Indonesia (2025)
• Thyroid Radiofrequency Ablation (RFA) Training, Dr. Soerojo General Hospital, Magelang, Indonesia (2026)
• European Group on Graves’ Orbitopathy (EuGOGO) Teaching Course, Essen, Germany (2026)

• Indonesian Medical Association, Central Jakarta Branch (2016 – Present)
• Indonesian Society of Internal Medicine Specialists, Jakarta Branch (2016 – Present)
• Indonesian Thyroid Association, Jakarta Branch (2021 – Present)
• Indonesian Endocrinology Association, Jakarta Branch (2023 – Present)
• Indonesian Osteoporosis Association (2024 – Present)
• Indonesian Society of Internal Medicine Specialists (2025 – Present)

• Second Place, Outstanding Medical Student Award, Faculty of Medicine, Universitas Indonesia (2007)
• Second Highest GPA (Cum Laude, GPA 3.84), Medical Doctor Graduation, Universitas Indonesia (2009)
• Rector’s Award, Universitas Indonesia Student Appreciation Night (2009)
• First Prize, Best Research Award, 1st Annual Scientific Meeting of Epidemiology, Depok (2009)
• First Prize, Pfizer Award for Sexology, Indonesian Association of Sexology (2009)
• Graduated Cum Laude (GPA 3.74), Master’s Degree in Epidemiology, Universitas Indonesia (2010)
• Travel Grant Award, 42nd Asia Pacific Academic Public Health Conference, Bali (2010)
• First Prize, Best Epidemiology Research Award, Medical Research Unit Competition, Faculty of Medicine, Universitas Indonesia (2011)
• First Prize, Best Research Award, 7th Malaysia–Indonesia–Brunei Conference, Malaysia (2011)
• Second Prize, Merck Diabetes Award, 9th National Congress of PERKENI, Manado (2012)
• First Prize, Acta Medica Indonesiana – Indonesian Journal of Internal Medicine Award (2012)
• Travel Grant Award, Asia Oceania Thyroid Association (AOTA) Congress, South Korea (2017)
• Graduated Cum Laude (GPA 3.86), Subspecialist in Endocrinology, Metabolism, and Diabetes, Faculty of Medicine, Universitas Indonesia (2023)
• First Prize, Best Oral Research Presentation, 11th National Endocrinology Forum, PERKENI, Jakarta (2023)
• Second Prize, Indonesian Award for Anti-Aging Medicine, National Symposium and Workshop on Anti-Aging Medicine (NASWAAM), Bali (2024)
• Graduated Summa Cum Laude (GPA 3.95), Doctoral Degree, Faculty of Public Health, Universitas Indonesia (2024)

1. Iodine deficiency disorders in Indonesia: an epidemiological and health policy review. Kesmas. 2009;4(2):71–7.
2. Prevalence and predictors of undiagnosed diabetes mellitus in Indonesia. Acta Med Indones – Indones J Intern Med. 2010;42(4):216–23.
3. Epidemiological model and scoring system for predicting rabies after dog’s bite during a rabies outbreak: a study from the Larat Rabies Outbreak. Med Health. 2011;6(1):148–9.
4. Ende diabetes study: diabetes and its characteristics in rural areas of East Nusa Tenggara. Med J Indones. 2013;22(1):30–8.
5. Successful treatment of discoid lupus erythematosus with chloroquine. Acta Med Indones – Indones J Intern Med. 2013;45(4):321–3.
6. Science and the art of case reporting in medicine. Acta Med Indones – Indones J Intern Med. 2013;45(4):324–8.
7. Kaposi sarcoma of the eye in an HIV patient well-responded to HAART. Acta Med Indones – Indones J Intern Med. 2014;46(3):253–5.
8. Hypertension and kidney dysfunction in the adult population in Indonesia. J Hypertens. 2015;33:e43.
9. Managing hypertriglyceridemia in daily practice. Acta Med Indones – Indones J Intern Med. 2015;47(3):265–71.
10. Recurrent bilateral staghorn stones as a manifestation of primary hyperparathyroidism due to parathyroid adenoma. Acta Med Indones – Indones J Intern Med. 2015;47(4):348–51.
11. Profile and analysis of chronic diabetes complications in the outpatient diabetes clinic of Cipto Mangunkusumo Hospital, Jakarta. Med J Indones. 2015;24(3):156–62.
12. Generalized hyperpigmentation caused by Addison’s disease in a patient with HIV/AIDS and multiple opportunistic infections. J ASEAN Fed Endocr Soc. 2015;30(2):169–73.
13. Management of Graves’ Disease During Pregnancy. Cermin Dunia Kedokteran. 2016;43(6):435–9.
14. Improvement of metabolic parameters resulting from levothyroxine therapy in a hypothyroid type 2 diabetes mellitus patient. Acta Med Indones – Indones J Intern Med. 2016;48(2):145–7.
15. Parathyroid adenoma in a young female presenting multiple fractures and postoperative hungry bone syndrome. Acta Med Indones – Indones J Intern Med. 2017;49(1):69–73.
16. Thyroid dysfunction in type 2 diabetes mellitus patients. Acta Med Indones – Indones J Intern Med. 2017;49(4):314–24.
17. Current diagnosis and management of Graves’ disease. Acta Med Indones – Indones J Intern Med. 2018;50(2):177–82.
18. Obesity and central obesity in Indonesia: evidence from a national health survey. Med J Indones. 2018;27(2):114–20.
19. Late diagnosis of congenital hypothyroidism in a young adult. Acta Med Indones – Indones J Intern Med. 2019;51(3):272–4.
20. Proportion of subclinical hypothyroidism in patients with diabetes mellitus. Int J Hum Health Sci. 2021;5(1):1–4.
21. COVID-19 and thyroid diseases: how the pandemic situation affects thyroid disease patients. J ASEAN Fed Endocr Soc. 2020;35(2):155–7.
22. Giant recurrent pituitary adenoma after three transsphenoidal surgeries, one craniotomy, and 30 sessions of external radiotherapy. Acta Med Indones – Indones J Intern Med. 2021;53(2):221–4.
23. Sight-threatening conditions in severe thyroid eye disease: how should we manage them? Acta Med Indones – Indones J Intern Med. 2022;54(1):124–30.
24. Successful treatment of severe and active Graves’ orbitopathy with tocilizumab after thyroidectomy and maximum-dose intravenous methylprednisolone. Acta Med Indones – Indones J Intern Med. 2023;55(4):475–7.